4//SEC Filing
ADMA BIOLOGICS, INC. 4
Accession 0001193805-15-000099
$ADMACIK 0001368514operating
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 7:00 PM ET
Size
5.8 KB
Accession
0001193805-15-000099
Insider Transaction Report
Form 4
Mond James
CSO/CMO
Transactions
- Award
Options to purchase
2015-01-30+22,000→ 22,000 totalExercise: $10.80Exp: 2025-01-30→ Common Stock (22,000 underlying)
Footnotes (2)
- [F1]The exercise price reflects the per share fair market value of the Company's common stock, as determined by the closing price of the Company's common stock on the NASADAQ Stock Market on January 30, 2015, the date that the option grant was approved by the Company's board of directors.
- [F2]These options vest over four years with 25% vesting on the one year anniversary of the date of grant and the remaining 75% vesting monthly in equal installments over the next three years.
Documents
Issuer
ADMA BIOLOGICS, INC.
CIK 0001368514
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001368514
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 7:00 PM ET
- Size
- 5.8 KB